Chlamydia Infections Global Clinical Trials Review, H2, 2014

Date: November 28, 2014
Pages: 67
Price:
US$ 2,500.00 US$ 2,000.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C8697446014EN
Leaflet:

Download PDF Leaflet

Chlamydia Infections Global Clinical Trials Review, H2, 2014

SUMMARY

GlobalData's clinical trial report, “Chlamydia Infections Global Clinical Trials Review, H2, 2014' provides data on the Chlamydia Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chlamydia Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chlamydia Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
REASONS TO BUY
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Chlamydia Infections
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Chlamydia Infections to Infectious Disease Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Chlamydia Infections to Infectious Disease Clinical Trials
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Chlamydia Infections
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Chlamydia Infections Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Kyorin Holdings, Inc.
Clinical Trial Overview of Kyorin Holdings, Inc.
Endo International plc
Clinical Trial Overview of Endo International plc
Cempra Pharmaceuticals, Inc.
Clinical Trial Overview of Cempra Pharmaceuticals, Inc.
ActivBiotics Pharma, LLC
Clinical Trial Overview of ActivBiotics Pharma, LLC
Actavis plc
Clinical Trial Overview of Actavis plc
Clinical Trial Overview of Top Institutes / Government
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Johns Hopkins University
Clinical Trial Overview of Johns Hopkins University
Centers for Disease Control and Prevention
Clinical Trial Overview of Centers for Disease Control and Prevention
National Heart, Lung, and Blood Institute
Clinical Trial Overview of National Heart, Lung, and Blood Institute
University of Pittsburgh
Clinical Trial Overview of University of Pittsburgh
The University of Melbourne
Clinical Trial Overview of The University of Melbourne
Washington University School of Medicine
Clinical Trial Overview of Washington University School of Medicine
London School of Hygiene & Tropical Medicine
Clinical Trial Overview of London School of Hygiene & Tropical Medicine
Population Council
Clinical Trial Overview of Population Council
Barts and The London NHS Trust
Clinical Trial Overview of Barts and The London NHS Trust
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Chlamydia Infections Therapeutics, Global, Clinical Trials by Region, 2014
Chlamydia Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Chlamydia Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Chlamydia Infections Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014
Chlamydia Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014
Chlamydia Infections Therapeutics Clinical Trials, North America, Top Countries, 2014
Chlamydia Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014
Chlamydia Infections Therapeutics Clinical Trials, Central and South America, Top Countries, 2014
Proportion of Chlamydia Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014
Chlamydia Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Chlamydia Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Chlamydia Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014
Chlamydia Infections Therapeutics, Global, Clinical Trials by Phase, 2014
Chlamydia Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014
Chlamydia Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014
Chlamydia Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014
Chlamydia Infections Therapeutics, Global, Suspended Clinical Trials, 2014
Chlamydia Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014
Chlamydia Infections Therapeutics, Global, Terminated Clinical Trials, 2014
Chlamydia Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Chlamydia Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014
Chlamydia Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Chlamydia Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Chlamydia Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyorin Holdings, Inc., 2014
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo International plc, 2014
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Cempra Pharmaceuticals, Inc., 2014
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by ActivBiotics Pharma, LLC, 2014
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2014
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Melbourne, 2014
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by London School of Hygiene & Tropical Medicine, 2014
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Population Council, 2014
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Barts and The London NHS Trust, 2014

LIST OF FIGURES

Chlamydia Infections Therapeutics, Global, Clinical Trials by Region (%), 20147
Chlamydia Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 20148
Chlamydia Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 20149
Chlamydia Infections Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 201410
Chlamydia Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 201411
Chlamydia Infections Therapeutics Clinical Trials, North America, Top Countries (%), 201412
Chlamydia Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 201413
Proportion of Chlamydia Infections to Infectious Disease Clinical Trials, G7 Countries (%), 201415
Chlamydia Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 201416
Chlamydia Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 201417
Proportion of Chlamydia Infections to Infectious Disease Clinical Trials, E7 Countries (%), 201418
Chlamydia Infections Therapeutics, Global, Clinical Trials by Phase (%), 201419
Chlamydia Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 201420
Chlamydia Infections Therapeutics, Global, Clinical Trials by Trial Status, 201421
Chlamydia Infections Therapeutics Clinical Trials, Global, by End Point Status, 201422
Chlamydia Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Chlamydia Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 201427
Chlamydia Infections Therapeutics Clinical Trials, Global, Key Sponsors, 201428
Chlamydia Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 201429
Chlamydia Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 201430
GlobalData Methodology
Skip to top


Ask Your Question

Chlamydia Infections Global Clinical Trials Review, H2, 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: